» Articles » PMID: 31361543

ENOS Deletion Impairs Mitochondrial Quality Control and Exacerbates Western Diet-induced NASH

Overview
Date 2019 Jul 31
PMID 31361543
Citations 25
Authors
Affiliations
Soon will be listed here.
Abstract

Dysregulated mitochondrial quality control leads to mitochondrial functional impairments that are central to the development and progression of hepatic steatosis to nonalcoholic steatohepatitis (NASH). Here, we identify hepatocellular localized endothelial nitric oxide synthase (eNOS) as a novel master regulator of mitochondrial quality control. Mice lacking eNOS were more susceptible to Western diet-induced hepatic inflammation and fibrosis in conjunction with decreased markers of mitochondrial biogenesis and turnover. The hepatocyte-specific influence was verified via magnetic activated cell sorting purified primary hepatocytes and in vitro siRNA-induced knockdown of eNOS. Hepatic mitochondria from eNOS knockout mice revealed decreased markers of mitochondrial biogenesis (PPARγ coactivator-1α, mitochondrial transcription factor A) and autophagy/mitophagy [BCL-2-interacting protein-3 (BNIP3), 1A/1B light chain 3B (LC3)], suggesting decreased mitochondrial turnover rate. eNOS knockout in primary hepatocytes exhibited reduced fatty acid oxidation capacity and were unable to mount a normal BNIP3 response to a mitophagic challenge compared with wild-type mice. Finally, we demonstrate that eNOS is required in primary hepatocytes to induce activation of the stress-responsive transcription factor nuclear factor erythroid 2-related factor 2 (). Thus, our data demonstrate that eNOS is an important regulator of hepatic mitochondrial content and function and NASH susceptibility.

Citing Articles

Impact and Mechanisms of Action of BDNF on Neurological Disorders, Cancer, and Cardiovascular Diseases.

Lei M, Liu Q, Nie J, Huang R, Mei Y, Pan D CNS Neurosci Ther. 2024; 30(12):e70138.

PMID: 39648800 PMC: 11626086. DOI: 10.1111/cns.70138.


Mitophagy in fibrotic diseases: molecular mechanisms and therapeutic applications.

Cui X, Zhou Z, Tu H, Wu J, Zhou J, Yi Q Front Physiol. 2024; 15:1430230.

PMID: 39183973 PMC: 11341310. DOI: 10.3389/fphys.2024.1430230.


Gut microbial metabolites in MASLD: Implications of mitochondrial dysfunction in the pathogenesis and treatment.

Zhang R, Yan Z, Zhong H, Luo R, Liu W, Xiong S Hepatol Commun. 2024; 8(7).

PMID: 38967596 PMC: 11227362. DOI: 10.1097/HC9.0000000000000484.


Liver Cell Mitophagy in Metabolic Dysfunction-Associated Steatotic Liver Disease and Liver Fibrosis.

Chen J, Jian L, Guo Y, Tang C, Huang Z, Gao J Antioxidants (Basel). 2024; 13(6).

PMID: 38929168 PMC: 11200567. DOI: 10.3390/antiox13060729.


The crosstalk between mitochondrial quality control and metal-dependent cell death.

Zhou Q, Ren C, Li J, Wang L, Duan Y, Yao R Cell Death Dis. 2024; 15(4):299.

PMID: 38678018 PMC: 11055915. DOI: 10.1038/s41419-024-06691-w.


References
1.
Rector R, Thyfault J, Morris R, Laye M, Borengasser S, Booth F . Daily exercise increases hepatic fatty acid oxidation and prevents steatosis in Otsuka Long-Evans Tokushima Fatty rats. Am J Physiol Gastrointest Liver Physiol. 2008; 294(3):G619-26. DOI: 10.1152/ajpgi.00428.2007. View

2.
Koliaki C, Szendroedi J, Kaul K, Jelenik T, Nowotny P, Jankowiak F . Adaptation of hepatic mitochondrial function in humans with non-alcoholic fatty liver is lost in steatohepatitis. Cell Metab. 2015; 21(5):739-46. DOI: 10.1016/j.cmet.2015.04.004. View

3.
Mohan S, Reddick R, Musi N, Horn D, Yan B, Prihoda T . Diabetic eNOS knockout mice develop distinct macro- and microvascular complications. Lab Invest. 2008; 88(5):515-28. DOI: 10.1038/labinvest.2008.23. View

4.
Azimifar S, Nagaraj N, Cox J, Mann M . Cell-type-resolved quantitative proteomics of murine liver. Cell Metab. 2014; 20(6):1076-87. DOI: 10.1016/j.cmet.2014.11.002. View

5.
Armstrong M, Adams L, Canbay A, Syn W . Extrahepatic complications of nonalcoholic fatty liver disease. Hepatology. 2013; 59(3):1174-97. DOI: 10.1002/hep.26717. View